Balt Group

Balt Group, established in 1977, is a distinguished leader in the neurovascular medical device sector. For over 45 years, the company has been at the forefront of innovation, collaborating closely with physicians and institutions to engineer sophisticated neurovascular solutions. As a premier global neurovascular platform, Balt Group is actively extending its expertise and pioneering spirit into the peripheral vascular space, signifying a strategic expansion beyond its traditional boundaries. The company operates with a workforce of 500-1,000 employees, dedicated to advancing medical technology. Balt Group's core offerings encompass a range of critical medical devices, including solutions categorized as stock, joint, economic, inclusive, environmental, and developing applications. This commitment to comprehensive product development is underpinned by a skilled team whose contributions are vital to the company's success. Further details about the individuals driving this innovation can be found by visiting Meet Balt Group's team. Financially, Balt Group reports a substantial revenue of $213.1M, reflecting its robust market position and operational efficiency. The company's recent funding round of $370M in December 2024, a significant Other Financing Round, underscores investor confidence and supports its ambitious growth strategies. This financial strength enables continued research and development, as well as market expansion. Comprehensive financial performance data and investment insights are available via Explore financial highlights.